Olaleken O. Oluwole 🇺🇸
Specializes in treating hematological malignancies using stem cell transplantation and cellular therapy. Founded the VICC cellular therapy research program and led its early institutional expansion. Work focuses on advancing cell therapy as a comprehensive resource for malignant and non-malignant disorders.
9:45 AM - 10:05 AM
Day 2 | Hematology Track
Kite Pharma Satellite Symposium:
From Bench to Bedside:Yescartas Real -World evidence and the path toward cure in aggressive lymphoma
10:05 AM - 10:25 AM
Day 2 | Hematology Track
DLBLC molecular subtypes, are we ready for individualized treatments?
5:35 PM - 5:55 PM
Day 2 | Hematology Track
Follicular lymphoma